Psoriasis Clinical Trial

Autoimmunity in the Pathogenesis of AF

Summary

This research study is being done to find out whether autoimmune mechanisms are associated with the development of atrial fibrillation.

View Full Description

Full Description

The study sets out to identify an explanation for the pathogenesis of AF, potentially forming the basis for designing novel targeted therapies to prevent or reverse this prevalent human disease. The overall objectives are to determine whether autoimmune diseases are associated with AF development and to identify specific diagnostic and prognostic biomarkers that will improve the ability to accurately predict risk of AF development. The study will prospectively enroll patients with and without AF and determine their serum cytokine levels and assess the functional responses of T cells on the basis of cytokine production after in vitro T-cell specific stimulation, using Luminex bead-based multiplex technology.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Cases: AF (Persistent, paroxysmal AF)
Controls 1: (No prior history of AF or inflammatory or autoimmune diseases)
Controls 2: (biopsy proven Psoriasis)

Exclusion Criteria:

Clinically apparent acute infections over the past 4 weeks
Chronic infections
Recent malignancies
Recent Radiation or chemotherapy
Chronic kidney disease (≥ stage 2)
Organ transplantation
History of chronic liver disease
Major surgery or invasive procedure in the past 6 months
Internal prosthesis
Receiving immunosuppressive therapy
Known rheumatologic diseases (except for the participants with psoriasis)
Females who are known to be pregnant

Study is for people with:

Psoriasis

Estimated Enrollment:

75

Study ID:

NCT03498729

Recruitment Status:

Completed

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic
Rochester Minnesota, 55905, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

75

Study ID:

NCT03498729

Recruitment Status:

Completed

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider